Advertisement
Screener

SOLIGENIX, INC. (SNGX) Receivables, Long-term Contracts or Programs

2.8 / 5 stars · 68/120 Roast Me

SOLIGENIX, INC. Receivables, Long-term Contracts or Programs

SOLIGENIX, INC. (SNGX) had Receivables, Long-term Contracts or Programs of $25.25 thousand as of 2024-03-31, per its 10-Q filed 2024-05-10.

Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current

us-gaap:ReceivablesLongTermContractsOrPrograms · last filed 2024-11-08

  • 2024-03-31: Receivables, Long-term Contracts or Programs $25.25K.
  • 2023-12-31: Receivables, Long-term Contracts or Programs $23.89K.
  • 2023-09-30: Receivables, Long-term Contracts or Programs $22.85K.
  • 2023-06-30: Receivables, Long-term Contracts or Programs $25.28K.
Period endReceivables, Long-term Contracts or Programs
2024-03-31$25.25K
10-Q · filed 2024-05-10
2023-12-31$23.89K
10-Q · filed 2024-11-08
2023-09-30$22.85K
10-Q · filed 2023-11-13
2023-06-30$25.28K
10-Q · filed 2023-08-21
2023-03-31$24.77K
10-Q · filed 2023-05-15
2022-12-31$104.20K
10-K · filed 2024-03-15
2022-09-30$100.37K
10-Q · filed 2022-11-10
2022-06-30$109.02K
10-Q · filed 2022-08-12
2022-03-31$121.24K
10-Q · filed 2022-05-13
2021-12-31$103.83K
10-K · filed 2023-03-31
2021-09-30$103.77K
10-Q · filed 2021-11-12
2021-06-30$106.60K
10-Q · filed 2021-08-13
2020-12-31$361.10K
10-K · filed 2022-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Imunon, Inc. (IMNN)United States$0.008B-0.56
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97